APO Research
Talk to an analyst

APO RESEARCH · REPORT

In Vivo PK Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global In Vivo PK Services Market Analysis and Forecast 2026-2032

12 August 2026172 pages

Choose your research edition.

Industry ResearchIn Vivo PK Services Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal In Vivo PK Services Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal In Vivo PK Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In Vivo PK Services Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal In Vivo PK Services Market Analysis and Forecast 2026-2032172 pages · $4,950 USD

Market perspective

The global In Vivo PK Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for In Vivo PK Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for In Vivo PK Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for In Vivo PK Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for In Vivo PK Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of In Vivo PK Services include Microconstants, SCYNEXIS ADMET, Frontage, Drug Development Solutions, Altasciences, NorthEast BioLab, Eurofins, BioPharma Services and Smithers, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for In Vivo PK Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of In Vivo PK Services, also provides the revenue of main regions and countries. Of the upcoming market potential for In Vivo PK Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the In Vivo PK Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global In Vivo PK Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for In Vivo PK Services revenue, projected growth trends, production technology, application and end-user industry.

In Vivo PK Services Segment by Company

Microconstants

SCYNEXIS ADMET

Frontage

Drug Development Solutions

Altasciences

NorthEast BioLab

Eurofins

BioPharma Services

Smithers

Pacific BioLabs

Accelera

SGS

In Vivo PK Services Segment by Type

Biological Sample Development

Biological Sample Verification

Biological Sample Testing

In Vivo PK Services Segment by Application

Hospital

Clinic

Research Institutions

In Vivo PK Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vivo PK Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In Vivo PK Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vivo PK Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of In Vivo PK Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of In Vivo PK Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In Vivo PK Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global In Vivo PK Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Biological Sample Development Major Player Table 3. Biological Sample Verification Major Player Table 4. Biological Sample Testing Major Player Table 5. Global In Vivo PK Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Player Table 7. Clinic Major Player Table 8. Research Institutions Major Player Table 9. In Vivo PK Services Industry Trends Table 10. In Vivo PK Services Industry Drivers Table 11. In Vivo PK Services Industry Opportunities and Challenges Table 12. In Vivo PK Services Industry Restraints Table 13. Global In Vivo PK Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global In Vivo PK Services Market Size by Region (2021-2026) & (US$ Million) Table 15. Global In Vivo PK Services Market Share by Region (2021-2026) Table 16. Global In Vivo PK Services Market Size by Region (2027-2032) & (US$ Million) Table 17. Global In Vivo PK Services Market Share by Region (2027-2032) Table 18. Global In Vivo PK Services Revenue by Players (US$ Million) & (2021-2026) Table 19. Global In Vivo PK Services Revenue Market Share by Players (2021-2026) Table 20. Global In Vivo PK Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global In Vivo PK Services Key Players Headquarters & Area Served Table 22. Global In Vivo PK Services Players, Product Type & Application Table 23. Global In Vivo PK Services Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global In Vivo PK Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global In Vivo PK Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global In Vivo PK Services Revenue by Type (2021-2026) & (US$ Million) Table 28. Global In Vivo PK Services Revenue by Type (2027-2032) & (US$ Million) Table 29. Global In Vivo PK Services Revenue Market Share by Type (2021-2026) Table 30. Global In Vivo PK Services Revenue Market Share by Type (2027-2032) Table 31. Global In Vivo PK Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global In Vivo PK Services Revenue by Application (2021-2026) & (US$ Million) Table 33. Global In Vivo PK Services Revenue by Application (2027-2032) & (US$ Million) Table 34. Global In Vivo PK Services Revenue Market Share by Application (2021-2026) Table 35. Global In Vivo PK Services Revenue Market Share by Application (2027-2032) Table 36. Microconstants Company Information Table 37. Microconstants Business Overview Table 38. Microconstants In Vivo PK Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Microconstants In Vivo PK Services Product Portfolio Table 40. Microconstants Recent Development Table 41. SCYNEXIS ADMET Company Information Table 42. SCYNEXIS ADMET Business Overview Table 43. SCYNEXIS ADMET In Vivo PK Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. SCYNEXIS ADMET In Vivo PK Services Product Portfolio Table 45. SCYNEXIS ADMET Recent Development Table 46. Frontage Company Information Table 47. Frontage Business Overview Table 48. Frontage In Vivo PK Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Frontage In Vivo PK Services Product Portfolio Table 50. Frontage Recent Development Table 51. Drug Development Solutions Company Information Table 52. Drug Development Solutions Business Overview Table 53. Drug Development Solutions In Vivo PK Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Drug Development Solutions In Vivo PK Services Product Portfolio Table 55. Drug Development Solutions Recent Development Table 56. Altasciences Company Information Table 57. Altasciences Business Overview Table 58. Altasciences In Vivo PK Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Altasciences In Vivo PK Services Product Portfolio Table 60. Altasciences Recent Development Table 61. NorthEast BioLab Company Information Table 62. NorthEast BioLab Business Overview Table 63. NorthEast BioLab In Vivo PK Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. NorthEast BioLab In Vivo PK Services Product Portfolio Table 65. NorthEast BioLab Recent Development Table 66. Eurofins Company Information Table 67. Eurofins Business Overview Table 68. Eurofins In Vivo PK Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Eurofins In Vivo PK Services Product Portfolio Table 70. Eurofins Recent Development Table 71. BioPharma Services Company Information Table 72. BioPharma Services Business Overview Table 73. BioPharma Services In Vivo PK Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. BioPharma Services In Vivo PK Services Product Portfolio Table 75. BioPharma Services Recent Development Table 76. Smithers Company Information Table 77. Smithers Business Overview Table 78. Smithers In Vivo PK Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Smithers In Vivo PK Services Product Portfolio Table 80. Smithers Recent Development Table 81. Pacific BioLabs Company Information Table 82. Pacific BioLabs Business Overview Table 83. Pacific BioLabs In Vivo PK Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Pacific BioLabs In Vivo PK Services Product Portfolio Table 85. Pacific BioLabs Recent Development Table 86. Accelera Company Information Table 87. Accelera Business Overview Table 88. Accelera In Vivo PK Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Accelera In Vivo PK Services Product Portfolio Table 90. Accelera Recent Development Table 91. SGS Company Information Table 92. SGS Business Overview Table 93. SGS In Vivo PK Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. SGS In Vivo PK Services Product Portfolio Table 95. SGS Recent Development Table 96. North America In Vivo PK Services Revenue by Type (2021-2026) & (US$ Million) Table 97. North America In Vivo PK Services Revenue by Type (2027-2032) & (US$ Million) Table 98. North America In Vivo PK Services Revenue by Application (2021-2026) & (US$ Million) Table 99. North America In Vivo PK Services Revenue by Application (2027-2032) & (US$ Million) Table 100. North America In Vivo PK Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America In Vivo PK Services Revenue by Country (2021-2026) & (US$ Million) Table 102. North America In Vivo PK Services Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe In Vivo PK Services Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe In Vivo PK Services Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe In Vivo PK Services Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe In Vivo PK Services Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe In Vivo PK Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe In Vivo PK Services Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe In Vivo PK Services Revenue by Country (US$ Million) & (2027-2032) Table 110. China In Vivo PK Services Revenue by Type (2021-2026) & (US$ Million) Table 111. China In Vivo PK Services Revenue by Type (2027-2032) & (US$ Million) Table 112. China In Vivo PK Services Revenue by Application (2021-2026) & (US$ Million) Table 113. China In Vivo PK Services Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia In Vivo PK Services Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia In Vivo PK Services Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia In Vivo PK Services Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia In Vivo PK Services Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia In Vivo PK Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia In Vivo PK Services Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia In Vivo PK Services Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA In Vivo PK Services Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA In Vivo PK Services Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA In Vivo PK Services Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA In Vivo PK Services Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA In Vivo PK Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA In Vivo PK Services Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA In Vivo PK Services Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. In Vivo PK Services Image Figure 2. Global In Vivo PK Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global In Vivo PK Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Biological Sample Development Image Figure 5. Biological Sample Verification Image Figure 6. Biological Sample Testing Image Figure 7. Global In Vivo PK Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global In Vivo PK Services Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Research Institutions Image Figure 12. Global In Vivo PK Services Market Size (US$ Million) & (2021-2032) Figure 13. Global In Vivo PK Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global In Vivo PK Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global In Vivo PK Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global In Vivo PK Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global In Vivo PK Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global In Vivo PK Services Revenue Market Share by Type (2021-2032) Figure 20. Global In Vivo PK Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global In Vivo PK Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global In Vivo PK Services Revenue Market Share by Application (2021-2032) Figure 23. North America In Vivo PK Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America In Vivo PK Services Revenue Share by Type (2021-2032) Figure 25. North America In Vivo PK Services Revenue Share by Application (2021-2032) Figure 26. North America In Vivo PK Services Revenue Share by Country (2021-2032) Figure 27. United States In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe In Vivo PK Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe In Vivo PK Services Revenue Share by Type (2021-2032) Figure 32. Europe In Vivo PK Services Revenue Share by Application (2021-2032) Figure 33. Europe In Vivo PK Services Revenue Share by Country (2021-2032) Figure 34. Germany In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China In Vivo PK Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China In Vivo PK Services Revenue Share by Type (2021-2032) Figure 44. China In Vivo PK Services Revenue Share by Application (2021-2032) Figure 45. Asia In Vivo PK Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia In Vivo PK Services Revenue Share by Type (2021-2032) Figure 47. Asia In Vivo PK Services Revenue Share by Application (2021-2032) Figure 48. Asia In Vivo PK Services Revenue Share by Region (2021-2032) Figure 49. Japan In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA In Vivo PK Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA In Vivo PK Services Revenue Share by Type (2021-2032) Figure 57. SAMEA In Vivo PK Services Revenue Share by Application (2021-2032) Figure 58. SAMEA In Vivo PK Services Revenue Share by Country (2021-2032) Figure 59. Brazil In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt In Vivo PK Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Biological Sample Development
  • Biological Sample Verification
  • Biological Sample Testing
Applications
  • Hospital
  • Clinic
  • Research Institutions
Companies covered
  • Microconstants
  • SCYNEXIS ADMET
  • Frontage
  • Drug Development Solutions
  • Altasciences
  • NorthEast BioLab
  • Eurofins
  • BioPharma Services
  • Smithers
  • Pacific BioLabs
  • Accelera
  • SGS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 In Vivo PK Services Market by Type
  3. 1.2.1 Global In Vivo PK Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Biological Sample Development
  5. 1.2.3 Biological Sample Verification
  6. 1.2.4 Biological Sample Testing
  7. 1.3 In Vivo PK Services Market by Application
  8. 1.3.1 Global In Vivo PK Services Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Research Institutions
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 In Vivo PK Services Market Dynamics
  1. 2.1 In Vivo PK Services Industry Trends
  2. 2.2 In Vivo PK Services Industry Drivers
  3. 2.3 In Vivo PK Services Industry Opportunities and Challenges
  4. 2.4 In Vivo PK Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global In Vivo PK Services Market Perspective (2021-2032)
  2. 3.2 Global In Vivo PK Services Growth Trends by Region
  3. 3.2.1 Global In Vivo PK Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global In Vivo PK Services Market Size by Region (2021-2026)
  5. 3.2.3 Global In Vivo PK Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global In Vivo PK Services Revenue by Players
  2. 4.1.1 Global In Vivo PK Services Revenue by Players (2021-2026)
  3. 4.1.2 Global In Vivo PK Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global In Vivo PK Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global In Vivo PK Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global In Vivo PK Services Key Players Headquarters & Area Served
  7. 4.4 Global In Vivo PK Services Players, Product Type & Application
  8. 4.5 Global In Vivo PK Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global In Vivo PK Services Market CR5 and HHI
  11. 4.6.3 2025 In Vivo PK Services Tier 1, Tier 2, and Tier 3
5 In Vivo PK Services Market Size by Type
  1. 5.1 Global In Vivo PK Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global In Vivo PK Services Revenue by Type (2021-2032)
  3. 5.3 Global In Vivo PK Services Revenue Market Share by Type (2021-2032)
6 In Vivo PK Services Market Size by Application
  1. 6.1 Global In Vivo PK Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global In Vivo PK Services Revenue by Application (2021-2032)
  3. 6.3 Global In Vivo PK Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Microconstants
  2. 7.1.1 Microconstants Company Information
  3. 7.1.2 Microconstants Business Overview
  4. 7.1.3 Microconstants In Vivo PK Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Microconstants In Vivo PK Services Product Portfolio
  6. 7.1.5 Microconstants Recent Developments
  7. 7.2 SCYNEXIS ADMET
  8. 7.2.1 SCYNEXIS ADMET Company Information
  9. 7.2.2 SCYNEXIS ADMET Business Overview
  10. 7.2.3 SCYNEXIS ADMET In Vivo PK Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 SCYNEXIS ADMET In Vivo PK Services Product Portfolio
  12. 7.2.5 SCYNEXIS ADMET Recent Developments
  13. 7.3 Frontage
  14. 7.3.1 Frontage Company Information
  15. 7.3.2 Frontage Business Overview
  16. 7.3.3 Frontage In Vivo PK Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Frontage In Vivo PK Services Product Portfolio
  18. 7.3.5 Frontage Recent Developments
  19. 7.4 Drug Development Solutions
  20. 7.4.1 Drug Development Solutions Company Information
  21. 7.4.2 Drug Development Solutions Business Overview
  22. 7.4.3 Drug Development Solutions In Vivo PK Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Drug Development Solutions In Vivo PK Services Product Portfolio
  24. 7.4.5 Drug Development Solutions Recent Developments
  25. 7.5 Altasciences
  26. 7.5.1 Altasciences Company Information
  27. 7.5.2 Altasciences Business Overview
  28. 7.5.3 Altasciences In Vivo PK Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Altasciences In Vivo PK Services Product Portfolio
  30. 7.5.5 Altasciences Recent Developments
  31. 7.6 NorthEast BioLab
  32. 7.6.1 NorthEast BioLab Company Information
  33. 7.6.2 NorthEast BioLab Business Overview
  34. 7.6.3 NorthEast BioLab In Vivo PK Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 NorthEast BioLab In Vivo PK Services Product Portfolio
  36. 7.6.5 NorthEast BioLab Recent Developments
  37. 7.7 Eurofins
  38. 7.7.1 Eurofins Company Information
  39. 7.7.2 Eurofins Business Overview
  40. 7.7.3 Eurofins In Vivo PK Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Eurofins In Vivo PK Services Product Portfolio
  42. 7.7.5 Eurofins Recent Developments
  43. 7.8 BioPharma Services
  44. 7.8.1 BioPharma Services Company Information
  45. 7.8.2 BioPharma Services Business Overview
  46. 7.8.3 BioPharma Services In Vivo PK Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 BioPharma Services In Vivo PK Services Product Portfolio
  48. 7.8.5 BioPharma Services Recent Developments
  49. 7.9 Smithers
  50. 7.9.1 Smithers Company Information
  51. 7.9.2 Smithers Business Overview
  52. 7.9.3 Smithers In Vivo PK Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Smithers In Vivo PK Services Product Portfolio
  54. 7.9.5 Smithers Recent Developments
  55. 7.10 Pacific BioLabs
  56. 7.10.1 Pacific BioLabs Company Information
  57. 7.10.2 Pacific BioLabs Business Overview
  58. 7.10.3 Pacific BioLabs In Vivo PK Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Pacific BioLabs In Vivo PK Services Product Portfolio
  60. 7.10.5 Pacific BioLabs Recent Developments
  61. 7.11 Accelera
  62. 7.11.1 Accelera Company Information
  63. 7.11.2 Accelera Business Overview
  64. 7.11.3 Accelera In Vivo PK Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Accelera In Vivo PK Services Product Portfolio
  66. 7.11.5 Accelera Recent Developments
  67. 7.12 SGS
  68. 7.12.1 SGS Company Information
  69. 7.12.2 SGS Business Overview
  70. 7.12.3 SGS In Vivo PK Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 SGS In Vivo PK Services Product Portfolio
  72. 7.12.5 SGS Recent Developments
8 North America
  1. 8.1 North America In Vivo PK Services Revenue (2021-2032)
  2. 8.2 North America In Vivo PK Services Revenue by Type (2021-2032)
  3. 8.2.1 North America In Vivo PK Services Revenue by Type (2021-2026)
  4. 8.2.2 North America In Vivo PK Services Revenue by Type (2027-2032)
  5. 8.3 North America In Vivo PK Services Revenue Share by Type (2021-2032)
  6. 8.4 North America In Vivo PK Services Revenue by Application (2021-2032)
  7. 8.4.1 North America In Vivo PK Services Revenue by Application (2021-2026)
  8. 8.4.2 North America In Vivo PK Services Revenue by Application (2027-2032)
  9. 8.5 North America In Vivo PK Services Revenue Share by Application (2021-2032)
  10. 8.6 North America In Vivo PK Services Revenue by Country
  11. 8.6.1 North America In Vivo PK Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America In Vivo PK Services Revenue by Country (2021-2026)
  13. 8.6.3 North America In Vivo PK Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe In Vivo PK Services Revenue (2021-2032)
  2. 9.2 Europe In Vivo PK Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe In Vivo PK Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe In Vivo PK Services Revenue by Type (2027-2032)
  5. 9.3 Europe In Vivo PK Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe In Vivo PK Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe In Vivo PK Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe In Vivo PK Services Revenue by Application (2027-2032)
  9. 9.5 Europe In Vivo PK Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe In Vivo PK Services Revenue by Country
  11. 9.6.1 Europe In Vivo PK Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe In Vivo PK Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe In Vivo PK Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China In Vivo PK Services Revenue (2021-2032)
  2. 10.2 China In Vivo PK Services Revenue by Type (2021-2032)
  3. 10.2.1 China In Vivo PK Services Revenue by Type (2021-2026)
  4. 10.2.2 China In Vivo PK Services Revenue by Type (2027-2032)
  5. 10.3 China In Vivo PK Services Revenue Share by Type (2021-2032)
  6. 10.4 China In Vivo PK Services Revenue by Application (2021-2032)
  7. 10.4.1 China In Vivo PK Services Revenue by Application (2021-2026)
  8. 10.4.2 China In Vivo PK Services Revenue by Application (2027-2032)
  9. 10.5 China In Vivo PK Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia In Vivo PK Services Revenue (2021-2032)
  2. 11.2 Asia In Vivo PK Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia In Vivo PK Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia In Vivo PK Services Revenue by Type (2027-2032)
  5. 11.3 Asia In Vivo PK Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia In Vivo PK Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia In Vivo PK Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia In Vivo PK Services Revenue by Application (2027-2032)
  9. 11.5 Asia In Vivo PK Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia In Vivo PK Services Revenue by Country
  11. 11.6.1 Asia In Vivo PK Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia In Vivo PK Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia In Vivo PK Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA In Vivo PK Services Revenue (2021-2032)
  2. 12.2 SAMEA In Vivo PK Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA In Vivo PK Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA In Vivo PK Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA In Vivo PK Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA In Vivo PK Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA In Vivo PK Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA In Vivo PK Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA In Vivo PK Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA In Vivo PK Services Revenue by Country
  11. 12.6.1 SAMEA In Vivo PK Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA In Vivo PK Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA In Vivo PK Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst